| Drug Name | cabozantinib s-malate |
|---|---|
| Other Drug Names | JNJ-32729463-AAC |
| Chemical Name | Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1) |
| Formula | C28H24FN3O5.C4H6O5 |
| Mol. Wt. | 635.6 |
| CAS No. | 1140909-48-3 |
| UNII | DR7ST46X58 |
| Target-based Actions | Axl tyrosine kinase receptor inhibitor; Flt3 tyrosine kinase inhibitor; Hepatocyte growth factor antagonist; Kit tyrosine kinase inhibitor; MET tyrosine kinase receptor family inhibitor; RET tyrosine kinase receptor family inhibitor; Tek tyrosine kinase r |
| Highest Status | 2012年批准上市 |
| Originator Company | Exelixis, Inc. |
| Structure |
 |
Extended Information